Film-forming compositions for rooting cuttings
COUNTRY OF ORIGIN
BelarusIDENTIFIER
BO7172PUBLISHED
2023-07-01LAST UPDATE
2023-07-17DEADLINE
Linked profile in other language
Responsible
Elena Кniazeva
+375 17 251 5357
kniazeva@ibp.org.by
+375 17 251 5357
kniazeva@ibp.org.by
Summary
The Institute of Biophysics and Cell Engineering offers consumers film-forming compounds for rooting cuttings of fruit and ornamental crops under a manufacturing agreement and is looking for partners to conclude a distribution services agreement.
Description
Designed to optimize the process of rooting cuttings of fruit and ornamental crops.
Ingredients: polymers, growth regulators, trace elements, protective agents.
Provide acceleration of the formation of shoots and the root system of the cuttings; increase in the amount of rooted planting material by 30 - 50%; reduction of drug losses during processing.
Ingredients: polymers, growth regulators, trace elements, protective agents.
Provide acceleration of the formation of shoots and the root system of the cuttings; increase in the amount of rooted planting material by 30 - 50%; reduction of drug losses during processing.
Advantages and Innovations
They are well compatible with the basic technologies of propagating planting material.
Stage of development
Already on the market
Funding source
State budged
Internal
Internal
IPR status
Exclusive rights
Secret know-how
Secret know-how
Sector group
Agrofood
BioChemTech
BioChemTech
Client information
Type
R&D institution
Year established
1973
NACE keywords
A.01.61 - Support activities for crop production
M.72.11 - Research and experimental development on biotechnology
M.74.90 - Other professional, scientific and technical activities n.e.c.
Q.86.90 - Other human health activities
M.72.11 - Research and experimental development on biotechnology
M.74.90 - Other professional, scientific and technical activities n.e.c.
Q.86.90 - Other human health activities
Turnover (in EUR)
10-20M
Already engaged in transnational cooperation
Yes
Additional comments
Directions of fundamental and applied scientific researches of researches of the Institute.
In the field of medical biotechnology:
- genetic engineering - development of innovative biomedical cell products based on genetically modified cells;
- immunology and allergology - development of new methods of treatment and diagnosis of allergic diseases and immune dysfunctions;
- innovative vaccines - development of prototypes of domestic DNA and RNA vaccines for the prevention of viral diseases;
- new approaches to diagnostics - development of new technologies for early diagnosis of diseases and methods of personalized medicine aimed at improving the quality of human life;
- genome editing - somatic, induced pluripotent stem cells, which will allow to treat diseases, including orphan, genetic ones;
- synthetic morphogenesis - including engineering of tissues and organs.
In the field of bioinformatics technologies:
- structurally based design of new generation drugs, development of innovative targeted anticancer and antiviral drugs using structural bioinformatics methods;
- synthesis of targeted drugs and their testing under in vitro conditions.
In the field of nanotheranostics and personalized nanomedicine:
- development of means of targeted delivery of therapeutic drugs of a new generation using nanomaterials;
- development of biological nanochips for the diagnosis of diseases;
- study of biocompatible nanomaterials with a wide spectrum of action for the creation of biomedical cellular products, artificial organs, fundamentally new materials with antimicrobial, antiviral and anti-inflammatory activity.
Activities of the Center for Experimental and Applied Virology:
- cultivation of viruses, development of new methods of cultivation of human viruses to create diagnostic tools, medical prevention and treatment of viral diseases;
- creation of prototype vaccines - against influenza (inactivated and recombinant), against African swine fever (vector), against pulmonary tuberculosis (therapeutic based on donor dendritic cells), innovative drugs against influenza.
Over the past years, the Institute has been fulfilling a number of international contracts and agreements within the Framework Programs of the European Union, as well as with leading scientific centers, foundations, and societies.
In the field of medical biotechnology:
- genetic engineering - development of innovative biomedical cell products based on genetically modified cells;
- immunology and allergology - development of new methods of treatment and diagnosis of allergic diseases and immune dysfunctions;
- innovative vaccines - development of prototypes of domestic DNA and RNA vaccines for the prevention of viral diseases;
- new approaches to diagnostics - development of new technologies for early diagnosis of diseases and methods of personalized medicine aimed at improving the quality of human life;
- genome editing - somatic, induced pluripotent stem cells, which will allow to treat diseases, including orphan, genetic ones;
- synthetic morphogenesis - including engineering of tissues and organs.
In the field of bioinformatics technologies:
- structurally based design of new generation drugs, development of innovative targeted anticancer and antiviral drugs using structural bioinformatics methods;
- synthesis of targeted drugs and their testing under in vitro conditions.
In the field of nanotheranostics and personalized nanomedicine:
- development of means of targeted delivery of therapeutic drugs of a new generation using nanomaterials;
- development of biological nanochips for the diagnosis of diseases;
- study of biocompatible nanomaterials with a wide spectrum of action for the creation of biomedical cellular products, artificial organs, fundamentally new materials with antimicrobial, antiviral and anti-inflammatory activity.
Activities of the Center for Experimental and Applied Virology:
- cultivation of viruses, development of new methods of cultivation of human viruses to create diagnostic tools, medical prevention and treatment of viral diseases;
- creation of prototype vaccines - against influenza (inactivated and recombinant), against African swine fever (vector), against pulmonary tuberculosis (therapeutic based on donor dendritic cells), innovative drugs against influenza.
Over the past years, the Institute has been fulfilling a number of international contracts and agreements within the Framework Programs of the European Union, as well as with leading scientific centers, foundations, and societies.
Languages spoken
English
Russian
Russian
Information about partnership
Type of partnership considered
Distribution services agreement
Manufacturing agreement
Manufacturing agreement
Type and role of partner sought
Consumers interested in purchasing film-forming compounds for rooting cuttings of fruit and ornamental crops under a manufacturing agreement.
Partners interested in purchasing film-forming compounds for rooting cuttings of fruit and ornamental crops under a distribution services agreement.
Partners interested in purchasing film-forming compounds for rooting cuttings of fruit and ornamental crops under a distribution services agreement.
Type and size of partner sought
> 500 MNE
> 500
251-500
SME 51-250
SME 11-50
SME <= 10
R&D Institution
University
Sole proprietor
> 500
251-500
SME 51-250
SME 11-50
SME <= 10
R&D Institution
University
Sole proprietor
Количество уникальных просмотров в одной сессии: 980
Статистика ведется с 01.07.2023 20:50:44
Статистика ведется с 01.07.2023 20:50:44